Organism name | Piptanthus nepalensis |
---|---|
Genus | Piptanthus |
Family | Fabaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Piptanthus nepalensis |
---|---|
Linked NCBI taxonomy ID | 70606 |
Linked level | species |
Family in NCBI taxonomy | Fabaceae |
---|---|
ID | 3803 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00010106
![]() |
Genistein 7,4'-O-diglucoside
/ Genistein 7,4'-di-O-glucoside / Genistein-7,4'-di-O-beta-glucopyranoside |
No. 1 | No. 15 |
![]() |
||||
C00010080
![]() |
Daidzein 7,4'-di-O-glucoside
|
C047425
|
No. 1 | No. 15 |
![]() |
|||
C00010105
![]() |
Sophoricoside
/ Genistein 4'-O-glucoside |
CHEMBL486626
|
3 / 0 / 0 | No. 2 | No. 15 |
![]() |
||
C00010079
![]() |
Daidzein 4'-O-glucoside
|
CHEMBL1209148
|
No. 2 | No. 15 |
![]() |
|||
C00002553
![]() |
Ononin
/ Formononetin 7-O-glucoside |
CHEMBL465980
|
11 / 14 / 40 | No. 2 | No. 15 |
![]() |
||
C00002525
![]() |
Formononetin
/ 7-Hydroxy-4'-methoxyisoflavone |
CHEMBL242341
|
C007768
|
24 / 36 / 58 | 13 / 0 | No. 3 | No. 15 |
![]() |
C00009380
![]() |
Daidzein
/ 7,4'-Dihydroxyisoflavone |
CHEMBL8145
|
C004742
|
60 / 68 / 76 | 113 / 12 | No. 71 | No. 15 |
![]() |
C00002225
![]() |
Lupanine
/ (+)-Lupanine |
CHEMBL459396
CHEMBL520093 CHEMBL2008918 |
C008298
|
No. 85 | No. 3 |
![]() |
||
C00002216
![]() |
Caulophylline
/ N-Methylcytisine / (-)-N-Methylcytisine |
CHEMBL66191
CHEMBL1085045 |
C034245
|
No. 376 | No. 3 |
![]() |
||
C00002218
![]() |
Cytisine
/ (-)-Cytisine |
CHEMBL47039
CHEMBL497939 CHEMBL1628606 |
C004712
|
27 / 36 / 33 | 6 / 1 | No. 376 | No. 3 |
![]() |
C00002207
![]() |
Anagyrine
/ (-)-Anagyrine |
CHEMBL203399
CHEMBL509692 CHEMBL1324708 CHEMBL1454284 |
C012736
|
7 / 8 / 11 | No. 384 | No. 3 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002207 C00002218 C00002525 C00009380 C00010105 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002207 C00002218 C00002525 C00009380 | 1 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002207 C00002218 C00002525 C00009380 | 1 / 1 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002207 C00002525 C00009380 C00010105 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002207 C00002218 C00002525 | 1 / 2 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002525 C00002553 C00009380 | 7 / 37 |
O00255 | Menin | Unclassified protein | C00002207 C00002218 C00002525 | 2 / 5 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002207 C00002525 C00009380 | 3 / 3 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002218 C00002525 C00009380 | 0 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002218 C00002525 C00009380 | 0 / 1 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002525 C00002553 C00009380 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002218 C00002525 C00009380 | 4 / 3 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002553 C00009380 | 0 / 0 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00002525 C00009380 | 0 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00002525 C00009380 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002553 C00009380 | 1 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | C00002218 C00009380 | 11 / 10 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00009380 C00010105 | 0 / 0 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00002553 C00009380 | 1 / 1 |
P05091 | Aldehyde dehydrogenase, mitochondrial | Oxidoreductase | C00002553 C00009380 | 1 / 1 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002525 C00009380 | 2 / 2 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00002553 C00009380 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002525 C00009380 | 4 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002218 C00009380 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002525 C00009380 | 5 / 3 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002525 C00009380 | 0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00002525 C00002553 | 4 / 2 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002553 C00009380 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00002218 C00009380 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00002525 C00009380 | 0 / 0 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00009380 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00009380 | 1 / 8 |
P11387 | DNA topoisomerase 1 | Isomerase | C00009380 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00009380 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00009380 | 0 / 0 |
P11230 | Acetylcholine receptor subunit beta | CHRN beta | C00002218 | 2 / 1 |
P02708 | Acetylcholine receptor subunit alpha | CHRN alpha | C00002218 | 3 / 2 |
P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | C00002218 | 1 / 1 |
P07510 | Acetylcholine receptor subunit gamma | CHRN gamma | C00002218 | 2 / 1 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00009380 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00009380 | 0 / 1 |
P15121 | Aldose reductase | Enzyme | C00002553 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002218 | 0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00009380 | 1 / 0 |
P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | C00002218 | 1 / 1 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00002218 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00009380 | 0 / 1 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00009380 | 2 / 2 |
Q07001 | Acetylcholine receptor subunit delta | CHRN delta | C00002218 | 3 / 2 |
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00002218 | 0 / 0 |
P04745 | Alpha-amylase 1 | Enzyme | C00009380 | 0 / 0 |
P32297 | Neuronal acetylcholine receptor subunit alpha-3 | CHRN alpha | C00002218 | 1 / 0 |
P30926 | Neuronal acetylcholine receptor subunit beta-4 | CHRN beta | C00002218 | 0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00009380 | 2 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00002525 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00009380 | 3 / 1 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00009380 | 5 / 2 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00009380 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00009380 | 1 / 1 |
P03372 | Estrogen receptor | NR3A1 | C00009380 | 1 / 1 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00009380 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00009380 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00002218 | 6 / 4 |
P54132 | Bloom syndrome protein | Enzyme | C00009380 | 1 / 2 |
P14618 | Pyruvate kinase PKM | Enzyme | C00009380 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002553 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00009380 | 2 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00009380 | 1 / 1 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00009380 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00009380 | 3 / 4 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00002218 | 0 / 0 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00009380 | 0 / 0 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00009380 | 1 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00009380 | 1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00009380 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00009380 | 1 / 1 |
P31639 | Sodium/glucose cotransporter 2 | Glucose | C00002525 | 1 / 1 |
P13866 | Sodium/glucose cotransporter 1 | Glucose | C00002525 | 1 / 1 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002218 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002218 | 1 / 4 |
Q15822 | Neuronal acetylcholine receptor subunit alpha-2 | CHRN alpha | C00002218 | 1 / 1 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00009380 | 3 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00009380 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002525 | 0 / 0 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00009380 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00002525
C00009380
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002525
C00009380
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002525
C00009380
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002525
C00009380
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002525
C00009380
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00002525
C00009380
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00002525
C00009380
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00002525
C00009380
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00002525
C00009380
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002525
C00009380
|
11098 | PRSS23, SIG13, SPUVE, ZSIG13 | protease, serine, 23 |
C00009380
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00009380
|
249 | ALPL, AP-TNAP, APTNAP, HOPS, TNAP, TNSALP | alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) |
C00009380
|
251 | ALPPL2, ALPG, ALPPL, GCAP | alkaline phosphatase, placental-like 2 (EC:3.1.3.1) |
C00009380
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00009380
|
396 | ARHGDIA, GDIA1, NPHS8, RHOGDI, RHOGDI-1 | Rho GDP dissociation inhibitor (GDI) alpha |
C00009380
|
23545 | ATP6V0A2, A2, ARCL, ARCL2A, ATP6A2, ATP6N1D, J6B7, RTF, STV1, TJ6, TJ6M, TJ6S, VPH1, WSS | ATPase, H+ transporting, lysosomal V0 subunit a2 (EC:3.6.3.6) |
C00009380
|
11177 | BAZ1A, ACF1, WALp1, WCRF180, hACF1 | bromodomain adjacent to zinc finger domain, 1A |
C00009380
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00009380
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00009380
|
632 | BGLAP, BGP, OC, OCN | bone gamma-carboxyglutamate (gla) protein |
C00009380
|
672 | BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53 | breast cancer 1, early onset |
C00009380
|
103993 |
C00009380
|
||
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00009380
|
890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00009380
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00009380
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00009380
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00009380
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00009380
|
1103 | CHAT, CHOACTASE, CMS1A, CMS1A2 | choline O-acetyltransferase (EC:2.3.1.6) |
C00009380
|
1152 | CKB, B-CK, CKBB | creatine kinase, brain (EC:2.7.3.2) |
C00009380
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00009380
|
9167 | COX7A2L, COX7AR, COX7RP, EB1, SIG81 | cytochrome c oxidase subunit VIIa polypeptide 2 like |
C00009380
|
1374 | CPT1A, CPT1, CPT1-L, L-CPT1 | carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21) |
C00009380
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00009380
|
6387 | CXCL12, IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1, SDF1A, SDF1B | chemokine (C-X-C motif) ligand 12 |
C00009380
|
1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00009380
|
10057 | ABCC5, ABC33, EST277145, MOAT-C, MOATC, MRP5, SMRP, pABC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
C00009380
|
10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
C00009380
|
1589 | CYP21A2, CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B | cytochrome P450, family 21, subfamily A, polypeptide 2 (EC:1.14.99.10) |
C00009380
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00009380
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00009380
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00009380
|
1795 | DOCK3, MOCA, PBP | dedicator of cytokinesis 3 |
C00009380
|
1846 | DUSP4, HVH2, MKP-2, MKP2, TYP | dual specificity phosphatase 4 (EC:3.1.3.16 3.1.3.48) |
C00009380
|
9166 | EBAG9, EB9, PDAF | estrogen receptor binding site associated, antigen, 9 |
C00009380
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00009380
|
2027 | ENO3, GSD13, MSE | enolase 3 (beta, muscle) (EC:4.2.1.11) |
C00009380
|
2041 | EPHA1, EPH, EPHT, EPHT1 | EPH receptor A1 (EC:2.7.10.1) |
C00009380
|
83715 | ESPN, DFNB36 | espin |
C00009380
|
1135 | CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) |
C00002218
|
19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00009380
|
2101 | ESRRA, ERR1, ERRa, ERRalpha, ESRL1, NR3B1 | estrogen-related receptor alpha |
C00009380
|
2103 | ESRRB, DFNB35, ERR2, ERRb, ESRL2, NR3B2 | estrogen-related receptor beta |
C00009380
|
2104 | ESRRG, ERR3, ERRgamma, NR3B3 | estrogen-related receptor gamma |
C00009380
|
56776 | FMN2 | formin 2 |
C00009380
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00009380
|
9687 | GREB1 | growth regulation by estrogen in breast cancer 1 |
C00009380
|
3284 | HSD3B2, HSD3B, HSDB, SDR11E2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (EC:1.1.1.145 5.3.3.1) |
C00009380
|
7866 | IFRD2, IFNRP, SKMc15, SM15 | interferon-related developmental regulator 2 |
C00009380
|
3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00009380
|
3487 | IGFBP4, BP-4, HT29-IGFBP, IBP4, IGFBP-4 | insulin-like growth factor binding protein 4 |
C00009380
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00009380
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00009380
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00009380
|
26145 | IRF2BP1 | interferon regulatory factor 2 binding protein 1 |
C00009380
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00009380
|
26251 | KCNG2, KCNF2, KV6.2 | potassium voltage-gated channel, subfamily G, member 2 |
C00009380
|
354 | KLK3, APS, KLK2A1, PSA, hK3 | kallikrein-related peptidase 3 (EC:3.4.21.77) |
C00009380
|
27074 | LAMP3, CD208, DC_LAMP, DC-LAMP, DCLAMP, LAMP, LAMP-3, TSC403 | lysosomal-associated membrane protein 3 |
C00009380
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00009380
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00009380
|
4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00009380
|
4502 | MT2A, MT2 | metallothionein 2A |
C00009380
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00009380
|
10499 | NCOA2, GRIP1, KAT13C, NCoA-2, SRC2, TIF2, bHLHe75 | nuclear receptor coactivator 2 |
C00009380
|
4824 | NKX3-1, BAPX2, NKX3, NKX3.1, NKX3A | NK3 homeobox 1 |
C00009380
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00009380
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00009380
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00009380
|
8204 | NRIP1, RIP140 | nuclear receptor interacting protein 1 |
C00009380
|
56944 | OLFML3, HNOEL-iso, OLF44 | olfactomedin-like 3 |
C00009380
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00009380
|
5111 | PCNA | proliferating cell nuclear antigen |
C00009380
|
64236 | PDLIM2, MYSTIQUE, SLIM | PDZ and LIM domain 2 (mystique) |
C00009380
|
5174 | PDZK1, CAP70, CLAMP, NHERF-3, NHERF3, PDZD1 | PDZ domain containing 1 |
C00009380
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00009380
|
5411 | PNN, DRS, DRSP, SDK3, memA | pinin, desmosome associated protein |
C00009380
|
10957 | PNRC1, B4-2, PNAS-145, PROL2, PRR2 | proline-rich nuclear receptor coactivator 1 |
C00009380
|
5458 | POU4F2, BRN3.2, BRN3B, Brn-3b | POU class 4 homeobox 2 |
C00009380
|
5580 | PRKCD, MAY1, PKCD, nPKC-delta | protein kinase C, delta (EC:2.7.10.2 2.7.11.13) |
C00009380
|
119 | ADD2, ADDB | adducin 2 (beta) |
C00009380
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00009380
|
5747 | PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK | protein tyrosine kinase 2 (EC:2.7.10.2) |
C00009380
|
5932 | RBBP8, COM1, CTIP, JWDS, RIM, SAE2, SCKL2 | retinoblastoma binding protein 8 |
C00009380
|
6197 | RPS6KA3, CLS, HU-3, ISPK-1, MAPKAPK1B, MRX19, RSK, RSK2, S6K-alpha3, p90-RSK2, pp90RSK2 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 (EC:2.7.11.1) |
C00009380
|
81537 | SGPP1, SPPase1 | sphingosine-1-phosphate phosphatase 1 |
C00009380
|
6558 | SLC12A2, BSC, BSC2, NKCC1 | solute carrier family 12 (sodium/potassium/chloride transporter), member 2 |
C00009380
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00009380
|
8140 | SLC7A5, 4F2LC, CD98, D16S469E, E16, LAT1, MPE16, hLAT1 | solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
C00009380
|
6781 | STC1, STC | stanniocalcin 1 |
C00009380
|
27347 | STK39, DCHT, PASK, SPAK | serine threonine kinase 39 (EC:2.7.11.1) |
C00009380
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00009380
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00009380
|
6870 | TACR3, HH11, NK-3R, NK3R, NKR, TAC3RL | tachykinin receptor 3 |
C00009380
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00009380
|
7041 | TGFB1I1, ARA55, HIC-5, HIC5, TSC-5 | transforming growth factor beta 1 induced transcript 1 |
C00009380
|
7130 | TNFAIP6, TSG-6, TSG6 | tumor necrosis factor, alpha-induced protein 6 |
C00009380
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00009380
|
9537 | TP53I11, PIG11 | tumor protein p53 inducible protein 11 |
C00009380
|
7164 | TPD52L1, D53, hD53 | tumor protein D52-like 1 |
C00009380
|
7345 | UCHL1, NDGOA, PARK5, PGP_9.5, PGP9.5, PGP95, Uch-L1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) (EC:3.4.19.12) |
C00009380
|
1143 | CHRNB4 | cholinergic receptor, nicotinic, beta 4 (neuronal) |
C00002218
|
1141 | CHRNB2, EFNL3, nAChRB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) |
C00002218
|
1139 | CHRNA7, CHRNA7-2, NACHRA7 | cholinergic receptor, nicotinic, alpha 7 (neuronal) |
C00002218
|
1137 | CHRNA4, BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) |
C00002218
|
1136 | CHRNA3, LNCR2, NACHRA3, PAOD2 | cholinergic receptor, nicotinic, alpha 3 (neuronal) |
C00002218
|
7367 | UGT2B17, BMND12, UDPGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 (EC:2.4.1.17) |
C00009380
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00009380
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00002525
|
2056 | EPO, EP, MVCD2 | erythropoietin |
C00002525
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00002525
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#610251 | Alcohol sensitivity, acute |
P05091
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#210900 | Bloom syndrome; blm |
P54132
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#218800 | Crigler-najjar syndrome, type i |
P22310
|
#606785 | Crigler-najjar syndrome, type ii |
P22310
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 |
P43681
|
#605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 |
P17787
|
#610353 | Epilepsy, nocturnal frontal lobe, 4; enfl4 |
Q15822
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#143500 | Gilbert syndrome |
P22310
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#606824 | Glucose/galactose malabsorption; ggm |
P13866
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#211980 | Lung cancer |
P00533
P04637 |
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#265000 | Multiple pterygium syndrome, escobar variant; evmps |
P07510
|
#253290 | Multiple pterygium syndrome, lethal type; lmps |
P02708
P07510 Q07001 |
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#608931 | Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency |
P11230
|
#608930 | Myasthenic syndrome, congenital, fast-channel |
P02708
Q07001 |
#601462 | Myasthenic syndrome, congenital, slow-channel; sccms |
P02708
P11230 Q07001 |
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P37231
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#233100 | Renal glucosuria; glys1 |
P31639
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#612052 | Smoking as a quantitative trait locus 3; sqtl3 |
P32297
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#278300 | Xanthinuria, type i |
P47989
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) |
H00018 | Gastric cancer |
P00533
(related)
P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
|
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00770 | Congenital myasthenic syndrome |
P02708
(related)
P11230 (related) Q07001 (related) |
H00986 | Multiple pterygium syndrome |
P02708
(related)
P07510 (related) Q07001 (related) |
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H01071 | Acute alcohol sensitivity |
P05091
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H01261 | Congenital glucose-galactose malabsorption (GGM) |
P13866
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) |
P17787
(related)
P43681 (related) Q15822 (related) |
H00548 | Brunner syndrome |
P21397
(related)
|
H01126 | Familial renal glucosuria (FRG) |
P31639
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D012640 | Seizures |
C00002218
|
D000230 | Adenocarcinoma |
C00009380
|
D000647 | Amnesia |
C00009380
|
D002318 | Cardiovascular Diseases |
C00009380
|
D003924 | Diabetes Mellitus, Type 2 |
C00009380
|
D004487 | Edema |
C00009380
|
D016889 | Endometrial Neoplasms |
C00009380
|
D007172 | Erectile Dysfunction |
C00009380
|
D006965 | Hyperplasia |
C00009380
|
D006973 | Hypertension |
C00009380
|
D017254 | Leukemic Infiltration |
C00009380
|
D008569 | Memory Disorders |
C00009380
|
D014693 | Ventricular Fibrillation |
C00009380
|